ANI Pharmaceuticals, Inc. (ANIP) free cash flow

Free cash flow · fiscal 2025
$150.90M

ANI Pharmaceuticals, Inc. (ANIP) generated free cash flow of $150.90M in fiscal 2025 (the year ended December 31, 2025). That is 220.6% higher than the $47.06M of fiscal 2024. Figures as of 18 Nov 2026, 11:49 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$150.90M
Change on fiscal 2024
+220.6%
Growth, 5 years
+75.2% a year
Growth, 10 years
+25.9% a year
Highest on record
$150.90Mfiscal 2025
Lowest on record
-$48.59Mfiscal 2011
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

ANI Pharmaceuticals, Inc. free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 75.2% a year; over ten years the rate was 25.9% a year. Across the 17 fiscal years on record (2009–2025), the highest was $150.90M in fiscal 2025 and the lowest -$48.59M in fiscal 2011.

History · 17 fiscal years

Free cash flow by fiscal year

ANI Pharmaceuticals, Inc. free cash flow, year by year

ANI Pharmaceuticals, Inc. (ANIP) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$150.90M 220.6% up
2024$47.06M 53.1% down
2023$100.45M—
2022-$47.66M 6,329.8% down
2021$765.00K 91.6% down
2020$9.13M 76.6% down
2019$39.00M 36.4% down
2018$61.33M 111.1% up
2017$29.05M 26.8% up
2016$22.91M 51.9% up
2015$15.08M 27.9% down
2014$20.91M—
2013-$5.68M—
2012-$429.00K—
2011-$48.59M—
2010-$40.16M—
2009-$18.60M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on ANIP

ANI Pharmaceuticals, Inc., figure by figure

ANI Pharmaceuticals, Inc. (ANIP) overview: price, valuation and scorecard

ANI Pharmaceuticals, Inc. free cash flow: questions and answers

What is ANI Pharmaceuticals, Inc.'s free cash flow?

ANI Pharmaceuticals, Inc. (ANIP) generated free cash flow of $150.90M in fiscal 2025 (the year ended December 31, 2025). That is 220.6% higher than the $47.06M of fiscal 2024.

What is the growth rate of ANI Pharmaceuticals, Inc.'s free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 75.2% a year; over ten years the rate was 25.9% a year.

What are the highest and lowest free cash flow figures on record for ANI Pharmaceuticals, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $150.90M in fiscal 2025 and the lowest -$48.59M in fiscal 2011.

How is ANI Pharmaceuticals, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For ANI Pharmaceuticals, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ANI Pharmaceuticals, Inc. (ANIP) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ANIP/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.